The OPPS included UWB1.289, an ovarian cancer cell line with a loss of BRCA1 function, and UW1.289 + BRCA1, a cell line engineered from UWB1.289 to restore wild-type BRCA1 function28. This evidence concerns the gene BRCA1 and ovarian cancer.